Vaccines aren’t the best at protecting against virus variants because they focus on a specific strain. According to a recent Medgadget article, a team of researchers at Northwestern University has a new strategy to fight the virus that is unlikely to be affected by changes in future variants. They discovered natural extracellular vesicles in the blood that act as a decoy binding site for viral particles and prevent them from binding to and infecting cells.
Anti-COVID Nanobubbles Block the Virus from Infecting Cells
The team behind the discovery hopes to develop the nanostructures into a nasal spray therapeutic to fight COVID-19.
Feb 2, 2022
List: Digitalization Companies From PACK EXPO
Looking for CPG-focused digital transformation solutions? Download our editor-curated list from PACK EXPO featuring top companies offering warehouse management, ERP, digital twin, and MES software with supply chain visibility and analytics capabilities—all tailored specifically for CPG operations.
Download Now
FDA warning letters surge - is your team prepared?
New guide reveals expert strategies to prevent regulatory issues and respond effectively to FDA enforcement actions in pharmaceutical and medical device manufacturing.
Read More
